Skip to main content

Table 2 Univariate and multivariate analyses of 95GC and other clinicopathological factors

From: Multicenter retrospective study on the use of Curebest™ 95GC Breast for estrogen receptor-positive and node-negative early breast cancer

Variable

Univariable analysis

Multivariable analysis

  

HR

95% CI

P

HR

95% CI

P

Age

≤50 vs > 50 years

0.60

0.19–1.90

0.3845

   

T stage

T2 vs T1

1.44

0.45–4.55

0.5385

   

Histologic grade

2 and 3 v 1

2.03

0.26–15.89

0.4986

   

PR

Positive vs Negative

0.46

0.14–1.53

0.2055

   

Ki-67

≥20% vs < 20%

3.69

1.16–11.67

0.0265

1.73

0.49–6.14

0.3982

PAM50

Others vs luminal A

5.74

0.74–44.56

0.0945

   

95GC

95GC-H vs 95GC-L

6.26

1.69–23.27

0.0061

5.14

1.24–21.37

0.0242

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us